Search - tctmd.com

Displaying 241 - 260 of 647

Sort: Relevancy | Date

Presentation TCT 2019

Introduction to Session

Presenter: Ajay Kirtane

September 27, 2019

Presentation TCT 2019

Treating Patients With Renal Insufficiency: Zero Contrast PCI

Presenter: Ziad Ali

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

Presenter: Joost Daemen

September 27, 2019

Presentation TCT 2019

The Target BP Program: Ongoing and Future Studies

Presenter: David Kandzari

September 27, 2019

Presentation TCT 2019

Clinical Evaluation: Peregrine Results to Date

Presenter: Felix Mahfoud

September 27, 2019

Presentation TCT 2019

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Presenter: Horst Sievert

September 27, 2019

Presentation TCT 2019

Alcohol-Mediated Renal Denervation: How is it Different?

Presenter: Melvin Lobo

September 27, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presentation TCT 2019

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

Presenter: David Israeli

September 26, 2019

Presentation TCT 2019

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

Presenter: Andrew Sharp

September 25, 2019

$TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up$

Presentation TCT 2019

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

Presenter: Daniil Maximkin

September 25, 2019

Presentation TCT 2019

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

Presenter: Byeong-Keuk Kim

September 25, 2019

Presentation TCT 2019

TCT 81: Quantification of Procedural and Anatomical Determinants of Multi-electrode Renal Denervation

Presenter: Abraham Tzafriri

September 25, 2019

Presentation TCT 2019

TCT 32: Clinical Outcomes of Imaging- and Physiology-guided PCI without Contrast Administration in Advanced Renal Failure

Presenter: Hussein Rahim

September 25, 2019

Presentation TCT 2019

TCT 31: Use of Iso-Osmolar Contrast Media in High AKI Risk Patients Undergoing Peripheral Revascularization Procedures Is Associated with Lower Incidence of Major Adverse Renal or Cardiac Events (MARCE)

Presenter: Anand Prasad

September 25, 2019

News Conference News TCT 2018

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

TCT Daily Staff

September 27, 2018

News Conference News TCT 2018

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

Todd Neale

September 26, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

Shelley Wood

September 25, 2018

Presentation TCT 2018

RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension

Presenter: Felix Mahfoud, Patrick W. Serruys, Philipp Lurz

September 25, 2018

Advertisement

Introduction to Session

Treating Patients With Renal Insufficiency: Zero Contrast PCI

Alcohol-Mediated Renal Denervation: 1-Year and Final Results From the Peregrine Postmarket Study

Endovascular Renal Sympathetic Denervation to Improve Heart Failure With Reduced Ejection Fraction: The IMPROVE HF-I Study

The Target BP Program: Ongoing and Future Studies

Clinical Evaluation: Peregrine Results to Date

Procedure Overview: Alcohol-mediated RDN Using the Peregrine System

Alcohol-Mediated Renal Denervation: How is it Different?

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Renal Vein Pressure Decompression for Advanced Decompensated Heart Failure (Magenta Medical)

TCT 607: Optimizing Safety and Efficacy of Lesion Formation for Percutaneous Renal Denervation: Human and Porcine Histological Analysis

TCT 605: Sympathetic renal denervation in patients with refractory arterial hypertension: two-year follow-up

TCT 82: Long-Term Clinical Outcomes After Renal Denervation in an Asian Population: Results From the Global SYMPLICITY Registry in South Korea (GSR Korea)

TCT 81: Quantification of Procedural and Anatomical Determinants of Multi-electrode Renal Denervation

TCT 32: Clinical Outcomes of Imaging- and Physiology-guided PCI without Contrast Administration in Advanced Renal Failure

TCT 31: Use of Iso-Osmolar Contrast Media in High AKI Risk Patients Undergoing Peripheral Revascularization Procedures Is Associated with Lower Incidence of Major Adverse Renal or Cardiac Events (MARCE)

Transcatheter Mitral Valve Repair Provides Fast, Sustained Gains in Quality of Life

RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation

TCT 2018, Day Four: Bioresorbable Scaffolds, Renal Denervation, Head-to-Head TAVR, INOCA, and . . . That’s a Wrap!

RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content